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Abstract
Background: Establishment of the health impact of hypertension on quality of life of Nigerians is a step towards
controlling the disease. The study aimed to provide a Nigerian specific reference list of utility scores of
hypertensive patients with various interacting conditions.
Findings: An interviewer-based, cross-sectional study was conducted using hypertensive patients in two
purposively selected tertiary hospitals located in South-Eastern Nigeria. Health Utility Index Mark 3 (HUI3) was used.
A total of 384 participants with either hypertension alone or with hypertension-associated complications were
interviewed in the two tertiary hospitals.
The overall mean utility score was 0.35 +/- 0.42. Patients with hypertension alone had the highest overall mean
utility score (0.57 +/- 0.29) while hypertensive patients with stroke had the lowest overall mean score (0.04 +/-
0.36). Being a male, increase in age and mean arterial blood pressure, emergency visit and loss of work due to
illness were associated with significant decrease in overall utility scores.
Conclusions: This study presented a reference for health state utilities of a population of Nigerian hypertensive
patients.
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Findings
Hypertension is a major cardiovascular risk factor.
Direct correlations between blood pressure (BP) values
and risk of cardiovascular diseases (CVDs) have been
established based principally on epidemiologic data.
Beginning at a benchmark BP of 115/75 mmHg, the risk
of CVD doubles with every increment of 20/10 mmHg
[1]. This finding is not peculiar to whites in developed
nations. The INTERHEART study showed that hyper-
tension is a strong contributor to the hazards of CVD in
black Africans, with odds ratio of 7.0 versus 2.3 in other
ethnic groups [2].
There is growing evidence that prevalence of hyper-
tension is on the increase in most sub-Saharan African
countries including Nigeria [3]. The current prevalence
in many developing countries, particularly in urban
societies, is said to be already as high as those seen in
developed countries [4,5]. The growing trend in preva-
lence of hypertension in Africa is supported by a num-
ber of reviews. A systematic review published in 2007,
showed that prevalence of hypertension in these regions
of the world could range from 14.2% to 39.1% (all age
standardized prevalence rates) [6]. Nigeria is not left out
in this epidemiological shift as prevalence of hyperten-
sion appears to be increasing in the nation [7].
Establishing the health impact of hypertension on
quality of life of Nigerians is a step towards checking
the disease. This will highlight the need to address the
emerging burden. For this, utility measures are often
employed. Economic evaluation of programmes to
detect and treat hypertension by improving awareness,
treatment and adherence and level of control has been
identified as a research priority in hypertension for
developing nations such as Nigeria [3] and utility esti-
mates are necessary for such evaluations. Utility esti-
mates which are preference based are employed as
quality weights for calculating the number of quality-
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The aim of this study is to provide a Nigerian specific
reference list of utility scores of hypertensive patients
with various interacting cardiovascular conditions. A
catalogue of utilities scores of Nigerian hypertensive
patients would enable more efficient economic analyses
of health interventions.
Methods
A descriptive study was conducted to assess a cross-sec-
tion of hypertensive patients with or without hyperten-
sion-associated complications [8] in two purposively
selected tertiary hospitals located in South-Eastern
Nigeria. These hospitals were University of Nigeria
Teaching Hospital Ituku-Ozalla and Ebonyi State Uni-
versity Teaching Hospital Abakaliki. The study was con-
ducted from August 2010 to January 2011. Study
participants included all the patients attending the out-
patient cardiology clinics in the two hospitals during the
period of study. Participants were included in the study
if they were diagnosed with hypertension (≥ 140/90
mmHg) and/or hypertension-associated complications as
specified in their medical record, consented to partici-
pate, and were sufficiently literate in English to answer
questions. Subjects were excluded if they had more than
one cormobidity, were at the end stage of sickness (as
indicated in their medical record), declined enrollment
or were unable or unwilling to give informed consent.
The interviewer-based, exit study was administered by 3
final year pharmacy students after having been trained
on how to administer the questionnaire.
The HUI3 was used to measure the health state utili-
ties of the patients. This measure is a preference-based
health related quality of life instrument that use multi-
attributable utility theory to assign valuations to differ-
ent health states [9]. Health states are defined by a clas-
sification system that include a set of dimensions or
attributes of health status, with a number for different
levels of each attribute [9]. The version of HUI instru-
ment employed in this study was the interviewer-admi-
nistered, 4 week recall, HUI3 version. In the HUI3
system, eight attributes including vision, hearing, speech,
ambulation, dexterity, emotion, cognition and pain and
discomfort define health status. Each attribute has five
or six levels, creating 972,000 unique HUI3 health states
[10]. Overall scores on the HUI3 range from-0.36 to 1.0,
with-0.36 representing the utility of the worst possible
HUI3 health state, and 0.0 representing dead and 1.0
representing perfect health. Differences of greater than
0.03 on the HUI2 or HUI3 overall scores may be con-
sidered important [10]. In addition to overall scores, sin-
gle attribute utility scores can be obtained for each
attribute of the HUI3, ranging from 0.0 to 1.0, with a
score of 0.0 representing the lowest level of functioning
[11]. Differences of 0.05 on the single attributes may be
considered clinically important [10]. A section to obtain
patients’ basic demographic and clinical information was
attached to the questionnaire. Information of patient’s
primary activity, whether patient had been off work due
to illness or had emergency visit in the last 6 month
were obtained through interview. Other variables were
obtained from the patient’s medical record.
To assess predictors of HUI scores, overall utility
score served as the dependent variable while some
selected patient’s demographic and clinical variables
served as independent variables. Study variables found
to be correlated to overall utility scores after adjusting
for confounding variables were used in a multiple linear
regression. Stepwise method was used to model the
effect of predictor variables on overall utility scores.
Analysis of impact of cardiovascular comordities on
overall utility scores of the patients was conducted using
ANOVA (LSD for multiple comparisons). Data analysis
was conducted with SPSS 11.0® (Chicago, Illinois, USA).
A two-tailed significance level of 0.05 was used.
All procedures were carried out according to a study
protocol approved by the Local Ethics Committee of
University of Nigeria Teaching Hospital Enugu (UNTH/
CSA.329.Vol.6) and Ebonyi State University Teaching
Hospital (EBSUTH/CMAC/RM/VOL1/046/48). Oral
informed consent was obtained. The information about
participant’s identity was not included with the other
data and only the principal investigator had access to
this information. No reference to the participant’s iden-
tity was made at any stage during data analysis
Results
A total of 635 patients were approached for interview
while only 384 participants (60.5%) with either hyperten-
sion alone or hypertension-associated complication par-
ticipated in the study. Lack of time or interest was the
major reason given by those that did not participate.
Each interview took an average of 6 minutes +/- 1 min-
ute. Majority of the participants were from University of
Nigeria Teaching Hospital and the ratio of male to
female was almost equal. A small number of the partici-
pants had no formal education. Other clinical variables
of the participants are shown in Table 1.
In Table 2, HUI3 single- and multi-attribute scores for
all the hypertensive patients and for those with cardiovas-
cular complications are shown. The overall mean utility
score was 0.35+/-0.42. Participants with hypertension
alone had the highest mean single- and multi-attribute uti-
lity scores. With the exception of the group of hyperten-
sive patients with heart failure, there was a significant
difference in the mean multi-attribute utility scores of the
other groups compared to patients with hypertension
alone. The mean single-attribute utility scores of patient
groups with cardiovascular comorbidities differed
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significantly compared to those with hypertension alone.
Apart from the vision attribute, patients with hypertension
and CHD had significantly differing mean single attribute
scores compared to patients with hypertension alone.
Patients with hypertension and stroke did not significantly
differ with patients with hypertension alone in the mean
hearing and speech attribute scores. Patients with hyper-
tension and heart failure did not differ significantly with
patient with hypertension alone except for the mean
vision, ambulation and dexterity attributes scores.
In Table 3, patients’ variables predicting decrement in
overall utility scores are shown. Being a male was asso-
ciated with statistical significant decrease in overall uti-
lity scores. Also, a unit increase in age (years), mean
arterial blood pressure (mmHg), emergency visit and
loss of work due to illness were associated with statisti-
cal significance decrease in overall utility scores. The F-
value (106.4, DF = 6) had an associated probability level
of p < 0.001, showing that the results were unlikely to
have arisen by sampling error.
Discussion
Health state utilities of Nigerian hypertensive patients
were assessed in this study employing a standard and
widely used quality of life measure, the Health Utilities
Index Mark 3 [10]. Although a number of generic
multi-attribute measures exist for assigning preference
weights (utilities) to health states e.g. Quality of Well-
Being Index [12], EuroQol EQ-5D [13], the Health Utili-
ties Index is one of the best standardized and most
widely respected measures [14]. In our study, the overall
utility scores for patients with hypertension alone and
those with cormobidites such as stroke, heart failure and
coronary heart disease were lower than the overall utility
scores that have been reported by other studies. A
national health survey conducted in Canada showed a
higher overall utility score of 0.82 ± 0.18 for hyperten-
sive participants, 068 ± 0.23 for stroke participants and
0.77 ± 0.21 for participants with heart disease when
compared with the results obtained in our survey [15].
Another cross-sectional survey of Australian prisoners
using SF-36 data transformed by both the SF-6D and
Nichol’s method reported utility scores for hypertensive
patients of 0.672 ± 0.176 and 0.782 ± 0.155 for SF-6D
and Nichol’s method of transformation respectively [16].
The lower overall utility score observed in this study
could be explained in part by the low socio-economic
Table 1 Demographic and Clinical Variables of
Participants (n = 384)

















Emergency visit 120 31.3
Hospitalization 228 59.4
Off work due to illness 216 56.3
Number of patient reported
symptoms
384 3.0 [3.0-4.0]
Age 384 61.0 [ 54.0-67.8]
Number of Physician visit last 1
year
384 6.0 [5.0-9.0]













Vision 0.86 ± 0.26 0.92 ± 0.16 0.86 ± 0.26* 0.88 ± 0.26 0.77 ± 0.31* < 0.001
Hearing 0.96 ± 0.14 0.98 ± 0.10 0.95 ± 0.14 0.88 ± 0.22* 0.98 ± 0.11 < 0.001
Speech 0.95 ± 0.14 0.98 ± 0.11 0.95 ± 0.20 0.91 ± 0.11* 0.95 ± 0.10 0.023
Ambulation 0.75 ± 0.37 0.97 ± 0.06 0.86 ± 0.32* 0.55 ± 0.40* 0.46 ± 0.41* < 0.001
Dexterity 0.83 ± 0.31 1.00 ± 0.00 0.89 ± 0.25* 0.69 ± 0.36* 0.62 ± 0.36* < 0.001
Emotion 0.74 ± 0.29 0.86 ± 0.18 0.84 ± 0.26 0.66 ± 0.30* 0.59 ± 0.32* < 0.001
Cognition 0.67 ± 0.29 0.78 ± 0.25 0.76 ± 0.26 0.53 ± 0.24* 0.51 ± 0.25* < 0.001
Pain 0.56 ± 0.35 0.71 ± 0.26 0.68 ± 0.31 0.34 ± 0.36* 0.34 ± 0.33* < 0.001
Overall 0.35 ± 0.42 0.57 ± 0.29 0.51 ± 0.38 0.13 ± 0.39* 0.04 ± 0.36* < 0.001
HF heart failure; CHD coronary heart disease
*Significantly different (p < 0.05) compared to hypertension alone group
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standards of the population of study. Nigeria is categor-
ized as a developing nation and has lower economic
indices compared to developed countries. Besides, the
level of health care in Nigerian health facilities is poorer
than those of developed countries. Thus it is logical that
study participants will perceive their level of health
poorly when compared to others living in more affluent
environments.
In this study, variables such as being a male as well as
increase in age and mean arterial blood pressure, emer-
gency visit to the hospital and loss of work due to illness
were all associated with decrease in overall utility scores.
Apart from sex (i.e. being a male) all the variables found
to lower overall utility scores are expected to cause
decrement in health related quality of life. It is impor-
tant to state that the findings from most quality of life
studies show the contrary (i.e. women have lower utili-
ties compared to men) [17,18]. This might need further
exploration in order to establish whether the reverse
occurs in African countries like Nigeria.
As established in this study, cardiovascular comorbid-
ities were associated with lower utility scores. Specifi-
cally, stroke did not have any negative impact on
hearing although it did affect vision. This finding is
somewhat in agreement with another study which found
that stroke and arthritis did not affect speech and cogni-
tion [19]. Coronary heart disease affected all the single
attributes except vision. This is expected since CHD
does not affect vision. Heart failure affected vision,
ambulation and dexterity significantly when compared
to patients with only hypertension. Although the health
related quality of life deficit on vision attribute score is
inexplicable, ambulation and dexterity is expected to be
affected.
This study had some limitations which should be
taken into consideration when interpreting the results.
The cross-sectional nature of the study and the con-
venience sampling may affect the generalizability of
the study. Secondly, the study made use of a small
sample size as a result language barrier which pre-
cluded those that could not understand and speak
English language.
Conclusion
This assessment presents a reference for health state uti-
lities of hypertensive patients with or without associated
complications. The utility scores could facilitate health
economic evaluations conducted to provide evidence for
decision making in health care.
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